Medimetriks Pharmaceuticals Inc., PharmaMar deal

PharmaMar granted Medimetriks a worldwide license to Kahalalide F and two of its analogs for uses outside cancer and neurology, for which PharmaMar will retain rights. Medimetriks plans to develop th...